Episode 3: Young Adult AML: Understanding the Gaps & Closing Them image

Episode 3: Young Adult AML: Understanding the Gaps & Closing Them

Posted on: May 05, 2025
Play Episode
Also available on
Description

AML is a complex and aggressive disease, but science is constantly evolving. This week we're talking about AML in young adults. Learn about the latest breakthroughs, unique challenges in treatment, and what’s next with Dr. Erin Feliciano, an AML AYA researcher.

 

Thank you for listening! Reach out to Mary at mary@healthtree.org if you are interested in joining our AYA Advisory Board or to share your thoughts on today's episode.

To keep learning about today's topic, check out this additional resource mentioned in today's episode!

Health Equity Article

 


If you want to talk to other listeners about this episode, join HealthTree Connect below and start the conversation! 

Join HealthTree Connect!

 

Overview
This episode explores the unique challenges faced by adolescents and young adults (AYAs) with acute myeloid leukemia (AML), focusing on survival disparities, the impact of race, financial and logistical barriers to treatment, and the importance of patient stories. Dr. Erin Feliciano discusses her research on survival disparities among AYA AML patients, highlighting the need for more inclusive research and better access to clinical trials. The conversation emphasizes the importance of understanding the holistic experiences of patients and the need for systemic changes in healthcare to address these disparities.
 
 
 
 
On this episode
Healthtree contact Mary Arnett

Mary Arnett

Mary joined HealthTree in 2022 as a part of HealthTree's team to help expand into all blood cancers. She now works as HealthTree's Volunteer & Community Outreach Manager, helping to engage and involve community members in HealthTree's mission. When she isn't working, she loves being the fun aunt to her 13 nieces and nephews, attending concerts, experimenting with new recipes in the kitchen, and traveling to explore new cities.
Healthtree contact Dr. Erin Feliciano

Dr. Erin Feliciano

Dr. Feliciano is an AML researcher focused on the AYA population out of Mount Sinai Hospital in New York City
Transcript

Related Content